Elizabeth L. Buza

Integrated BioTherapeutics (United States) — United States

Medicine · Health Sciences

29h-index4.4kcitations97works15.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peptidase Inhibition and Analysis(26), Virus-based gene therapy research(21), CAR-T cell therapy research(15), Ubiquitin and proteasome pathways(13), Cancer Immunotherapy and Biomarkers(11)

Publications96 total

Neuro Omics: Translational Neuropathology Applications of Spatial Technologies From Nonclinical Models to Human Disease
Toxicologic Pathology·2025
Normal Treg homeostasis and suppressive function require both FOXP1 and FOXP4
JCI Insight·2025· 1 citedOpen Access
Neuropathological Findings in Nonclinical Species Following Administration of Adeno-Associated Virus (AAV)-Based Gene Therapy Vectors
Toxicologic Pathology·2024· 7 cited
High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury
Molecular Therapy·2024· 55 citedOpen Access
Scientific and Regulatory Policy Committee Technical Review: Biology and Pathology of Ganglia in Animal Species Used for Nonclinical Safety Testing
Toxicologic Pathology·2023· 11 cited
Scientific and Regulatory Policy Committee Points to Consider: Sampling, Processing, Evaluation, Interpretation, and Reporting of Test Article-Related Ganglion Pathology for Nonclinical Toxicity Studies
Toxicologic Pathology·2023· 11 cited
Supplementary Figures S1 - S8 from <i>Hif1a</i> Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
2023Open Access
Supplementary Figures S1 - S8 from <i>Hif1a</i> Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
2023Open Access
Data from <i>Hif1a</i> Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
2023Open Access
Data from <i>Hif1a</i> Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
2023Open Access
Supplementary Table 3 from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Supplementary Figures 1-10. from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Supplementary Figure Legends from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Data from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Supplementary Table 1 from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Supplementary Table 2 from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Supplementary Figure Legends from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Data from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Supplementary Table 3 from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
Supplementary Table 1 from Systematic <i>In Vivo</i> Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
2023Open Access
page 1 of 5Next →

Frequent Co-authors

James M. Wilson(21), Peter Bell(15), Juliette Hordeaux(10), Christian Hinderer(8), Cecilia Dyer(8), Tamara Goode(7), Amy C. Durham(7), Jessica A. Chichester(7), Jenny A. Greig(7), Helen E. Heslop(6), Cliona M. Rooney(6), Catherine M. Bollard(6), Nathan Katz(5), Laura K. Richman(5), Hanying Yan(4), Yanqing Zhu(4), Roberto Calcedo(4), Sarah D. Cramer(4), Melanie K. Smith(4), James Monslow(3)